.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

HIV drug Aptivus gains new indication approval for kids

June 26, 2008

Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.

Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’